Richter-Helm BioLogics

Richter‑Helm BioLogics is a leading German CDMO specializing in the development and GMP manufacturing of biopharmaceuticals derived from bacteria and yeasts. With over three decades of experience, it offers end-to-end services including process development, analytics/QC testing, scale-up fermentation up to commercial supply (>1500L), and regulatory support for global markets. The company’s expertise spans recombinant proteins/peptides, antibody fragments/Nanobodies/VHHs/Fabs, vaccines (bacterial), and plasmid DNA using proprietary high-yield processes such as RHB-pART. Facilities are EMA/FDA/PMDA/MFDS approved with ongoing capacity expansions to meet growing demand.